J Toxicol Pathol 2011 24 924 Review Pulmonary Fibrosis Response Environmental Cues Molecular Targets Involved Its Pathogenesis Toshinori Yoshida1 Aya Ohnuma1 Haruka Horiuchi1 Takanori Harada2 1 Laboratory Pathology Toxicology Division The Institute Environmental Toxicology 4321 Uchimoriyamachi Joso Ibaraki 3030043 Japan 2 The Institute Environmental Toxicology 4321 Uchimoriyamachi Joso Ibaraki 3030043 Japan Abstract Chronic lung injury resulting variety different causes frequently associated develop ment pulmonary fibrosis humans Although etiology pulmonary fibrosis generally unknown sources evidence support hypothesis number environmental occupational agents play etiologic role pathogenesis disease The agents discussed review include beryllium nylon flock textile print ing aerosols polyvinyl chloride didecyldimethylammonium chloride The authors variety animal models including genetically modified mice order investigate molecular mechanism pulmonary fibrosis focusing chemokine receptors regulatory T cells transforming growth factorb bone morphogenetic protein signaling Overall propose concept toxicological pulmonary fibrosis lung disease induced response environmental cues DOI 101293tox249 J Toxicol Pathol 2011 24 924 Key words beryllium nylon flock DDAC TGFb chemokine receptor regulatory T cell Introduction Chronic lung injury resulting variety differ ent causes frequently associated development pulmonary fibrosis characterized replacement normal alveolar structure thickened extracel lular matrix ECM consequent reduction ca pacity gas exchange1 Interstitial lung diseases ILDs accurately known diffuse parenchymal lung dis eases DPLDs diverse group pulmonary disorders include idiopathic interstitial pneumonias IIPs druginduced ILDs occupational environmental lung diseases2 IIPs categorized heterogeneous clini copathologic disorders include nonspecific inter stitial pneumonia NSIP respiratory bronchiolitis RB RBassociated ILD RBILD cryptogenic organizing pneumonia COPorganizing pneumonia OP desquama tive interstitial pneumonia DIP lymphocytic interstitial pneumonia LIP acute interstitial pneumonia AIPdiffuse alveolar damage DAD idiopathic pulmonary fibrosis IPFusual interstitial pneumonia UIP 2011 The Japanese Society Toxicologic Pathology Received 29 October 2010 Accepted 25 November 2010 Mailing address Toshinori Yoshida Laboratory Pathology Toxi cology Division The Institute Environmental Toxicology 4321 Uchimoriyamachi Joso Ibaraki 3030043 Japan TEL 81297274521 FAX 81297274518 Email yoshidaietorjp defined American Thoracic SocietyEuropean Respi ratory Society consensus classification35 Table 1 IPFUIP common disorder IIPs characterized unrelenting progression fibrosis DIP RBILD related pathologically AIP characterized acute onset respiratory symptoms analogous acute respi ratory distress syndrome differing pre ceded identifiable catastrophic event5 Although etiology IPF generally unknown sources evidence support hypothesis number environmental occupational agents cigarette smoke agriculturefarming livestock wood dust metal dust stonesand play etiologic role patho genesis disease6 With respect occupational environmental lung diseases industrial revolution 19th century resulted widespread exposure dust promoted development diseases silicosis coal workers pneumoconiosis asbestosis improve ment working conditions resulted decrease cidence lung diseases2 In past 2030 years increase industrial processes led production use large number chemicals currently reported causes ILDs beryllium nylon flock textile printing aerosols polyvinyl chloride PVC organic vapors flavorings Sarcoidosis distinct entity ILDs granulomatous disease unknown eti ology occurring commonly lung non infectious environmental agents beryllium aluminum 10 Profibrotic Environmental Cues Table 1 Histopathological Pattern Interstitial lung Diseases ILD35 Clinical diagnosis Pathology NSIP NSIP RB COP DIP LIP AIP IPF RBILD OP DIP LIP DAD UIP Key features Cellular pattern Mild moderate interstitial chronic inf lammation hyperplasic pneumocytes Fibrosing pattern Diffuse thickening alveolar walls dense loose connective tissues interstitial chronic inflammation basically lacking UIP pattern preserving alveolar architecture Bronchiolocentric accumulation alveolar macrophages laden iron mild bronchiolar fibrosis chronic inflammation Patchy plugs loose connective tissues bronchiole adjacent alveolar ducts alveolar spaces mild interstitial chronic inflammation Marked alveolar accumulation macrophages laden iron mild interstitial thickening chronic inflammation Diffuse thickening alveolar walls infiltration T cells plasma cells macrophages MALT hyperplasia Diffuse alveolar wall thickening proliferation connective tissues inflammation deposition hyaline membranes Patch fibrosis remodeling lung structures fibroblast foci dense collagenous scaring overlying hyperplasic pneumocytes cystic changes honeycomb change lined columnar respiratory epitheliums NSIP nonspecific interstitial pneumonia RB respiratory bronchiolitis RBILD RBassociated ILD COP cryptogenic organizing pneumonia OP organizing pneumonia DIP desquamative interstitial pneumonia LIP lymphocytic interstitial pneumonia MALT mucosa associated lymphoid tissue AIP acute interstitial pneumonia DAD diffuse alveolar damage IPF idiopathic pulmonary fibrosis UIP usual interstitial pneumonia Table 2 Environmental Occupational Agents Pulmonary Fibrosis Chemicals Beryllium Nylon flock Textile paint PVC DDAC Disease ABDCBDΨ Key factorsMechanism References Hypersensitivity oxidative stress 10 11 16 23 24 Flock Workers Lung Hypersensitivity ironmediated Ardystil syndromeξ Pulmonary fibrosisΨ Acramine F Residual additives eosinophilia 4345 5052 Cytotoxicity inflammation 6365 69 3032 3741 PVC polyvinyl chloride DDAC didecyldimethylammonium chloride ABD acute beryllium disease CBD chronic beryllium disease Diagnosed lymphocytic bronchiolitis peribronchiolitis lymphoid hyperplasia ξ Diagnosed organizing pneumonia Ψ With granulomatous reaction Pulmonary fibrosis reported asthma occur based epidemiological studies zirconium produce pulmonary lesions similar sarcoidosis2 The agents discussed review include beryllium nylon flock textile printing aerosols PVC didecyldimethylammonium chloride DDAC Table 2 Common ILDcausing drugs include amiodarone antibiotics nonsteroidal antiinflammatory drugs chemo therapeutic agents bleomycin methotrexate nitro drugs produce virtually topathologic patterns interstitial pneumonia including NSIP OP DIP pulmonary granulomatosislike reac tion7 However review include druginduced ILDs bleomycin animal model discussing mechanism pulmonary fibrosis The pathogenesis pulmonary fibrosis complex involving innate adaptive immunoreactions ex ogenous environmental cues subsequent molecular cellular responses leading imbalance profibrogenic antifibrogenic effects healing processes This review focuses specific pathobiological mediators chemokines chemokine receptors regulatory T cells Tregs transforming growth factorb TGFb bone morphogenetic protein BMP signaling Beryllium Beryllium occurs naturally beryl lium aluminum silicate fourth lightest element hav ing low density 185 gcm3 20 C high melting point Yoshida Ohnuma Horiuchi et al 11 1287 C high tensile strength properties led incorporation hightechnology applications electronics aerospace machinery nuclear weapons manufacture89 Exposure beryllium workplaces continues public health concern ap proximately million individuals exposed potentially risk developing acute beryllium disease ABD chronic beryllium disease CBD involve hy persensitivity reactions beryllium1011 Genetic suscepti bility CBD linked major histocompatibility complex MHC class II isotype human leukocyte antigen HLADP alleles contain glutamic acid residue amino acid position 69 bchain1214 Among mouse strains FVBN AKR Balbc C3HHeJ C57BL6 DBA2 SJLJ FVBN strain reported responsive SJLJ C57BL6 strains shown highest responders15 CBD characterized presence noncapsu lating granulomatous inflammation lung sub sequent development progressive fibrosis16 Accumulat ing evidence clearly suggests CBD recognized immunemediated granulomatous reaction Six months single exposure AJ C3HHeJ mice beryllium 90 min lung responses comprised interstitial aggregates lymphocytesB cells centrally T cells peripherallyand granulomatous pneumonia characterized intraalveolar foamy macrophages giant cells neu trophils multifocal interstitial granulomas17 Evidence suggests recruitment berylliumspecific CD4 T cells lung significantly mediates immunopatho genesis CBD These CD4 T cells expressed effector memory T cell phenotype1013 secreted T helper 1 Th1type cytokines interferong IFNg interleukin2 IL2 tumor necrosis factora TNFa beryllium exposure1820 Programmed death1 member CD28 family negative regulator T cell function expressed significantly high levels bronchoalveo lar lavage BAL CD4 T cells CBD patients plausibly leading induction T cells preventing activation induced cell death21 Lately ABD recognized specific lymphocytic alveolitis nonspecific inflammatory process irritant11 Berylliumspecific CD8 T cells play minor role pathogen esis disease inferred results analysis BAL samples CBD patients10 Berylliuminduced oxidative stress plays role pathogenesis granulomatous inflammation CBD A crease intracellular thiols glutathione cysteine observed peripheral blood mononuclear cells beryl liumsensitized CBD patients berylliummediated T cell proliferation inhibited thiol antioxidant Nacetylcysteine catalytic antioxidant manganese III vitro22 Increased glutathione lung epithelial lin ing fluid CBD patients correlated glutathione peroxidase activity23 Heme oxygenase1 HO1 activity increased induced sputum CBD patients24 To gether data imply augmentation glutathione HO1mediated antioxidant systems involved process CBD Although cellular molecular mechanisms underly ing berylliosis investigated exact profibro genic factors identified far Mast cells contribute pathogenesis CBD serving important source 178kDa isoform basic fibroblast growth factor potent mitogenic chemotactic factor regulating fibroblast proliferation ECM produc tion25 In contrast beryllium low concentrations inhibits growth normal human fibroblasts proved G0 G1preS phase arrest senescence associated eleva tion p53 p21 p16 levels2627 At high concentra tions beryllium somewhat carcinogenic BALBc3T3 cells mouse embryonic fibroblast cell line28 TGFb signal ing CBD fully investigated Jonth et al 2007 reported codons 509 C 10T implicated production low levels TGFb1 pro tein shared susceptibility factors associated severe granulomatous inflammation CBD29 Thus inves tigations profibrogenicantifibrogenic signaling provide better understanding pathobiology CBD aid exploring therapeutic targets Nylon Flock Textile Paints Flock cut pulverized fibersynthetic natu ralof small diameter produces velvetlike coating applied adhesivecoated fabric material Flocked fabrics nylon polyamide rayon cellulose ac etate Dacron ethylene glycolterephthalic acid poly ester fibers increasingly popular especially upholstery coverings blankets Kern et al 2000 reported chronic nongranulomatous ILD termed Flock Workers Lung nylon flocking industry workers Rhode Island plant 1990s30 The workers developed BAL eosinophilia NSIP OP andor lymphocytic bronchiol itis interstitial fibrosis A small number North Ameri patients reported nylon flock related DIP At clinical pathology workshop hosted National Institute Occupational Safety Health consulting pulmonary pathologists diagnosed lymphocytic bronchiolitis peribronchiolitis lymphoid hyper plasia workers 5 nylon flock facilities 3 different US states Canadian province basis clinical examination histopathological findings31 This descrip tive terminology supported Centers Disease Control CDC clinicalpathological workshop hosted CDC32 Although nylon fibers act haptens trigger allergic reaction occupational asthma33 vivo exper iments failed demonstrate pulmonary hypersensitiv ity reactions nylon Airborne dust nylon flock collected nylon flocking plant interacted alveolar macro phages induced mildtomoderate multifocal suppu 12 Profibrotic Environmental Cues rative pneumonia bronchioles intratracheal instillation rats 10 mgkg body weight34 In rats exposed aerosols uncoated finishfree nylon respirablesized fibershaped particulates 6 hours day 5 days week 4 weeks significant increases lung weight indications pulmonary inflammation alveolar macrophage functional deficits compared trol rats35 Thus workers exposed high concentra tions nylon fiber dust increased risk ILDs suitable animal models developed clarify role nylon flock immunebased pulmonary diseases Synthetic fibers include metals Synthetic fibers present insoluble solidliquid interface surround ing host tissue fiber surface includes functional groups having ability mobilize metal endoge nous sources introducing metalcatalyzed oxidative stress lower respiratory tract Ghio et al 2006 reported ferruginous body accumulated iron func tions indicator metal accumulation potential oxidative stressor36 The clinical presentations 2 patients employed textile consistent chronic fibrotic disease lung areas traction bronchiectasis chronic inflammation bronchial metaplasia bronchiolitis mixed lym phocytic eosinophilic infiltration Staining resected tissue iron revealed structures having appearance ferruginous bodies Energy dispersive Xray analysis scanning electron microscopy revealed fibers iso lated lung carbonaceous originated Thus metal particularly iron play role pathogenesis Flock Workers Lung Besides synthetic fibers textile paints affect hu man health industries An outbreak severe spiratory disease called Ardystil syndrome occurred Community Valencia Spain factory workers worked textiles airsprayed dyes Acramin F paint Twentytwo cases OP identified 22 patients 6 died months37 Besides OP interstitial fibrosis DAD evident38 In study 1 year followup 27 patients heavily exposed textile sprays symptoms observed persist 15 cases39 The main polycationic components textile sprays Acramin FWR poly urea Acramin FWN polyamideamine Acrafix FHN polyamine nonpolycationic component Acramoll W Acramin FWR Acramin FWN Acrafix FHN exhibited considerable toxicity rat human type II pneumocytes alveolar macrophages Acramoll W nontoxic40 Consistent results vitro experiments lung damage caused Acramin FWR Acramin FWN Acrafix FHN mixture intratracheal instillation hamsters41 Protein concentra tion lactate dehydrogenase LDH activity inflammatory cell number percentage polymorphonuclear neutro phils increased BAL fluid week lung weight remained high month intratracheal instillation Inflammatory cell infiltration subsequent fibrosis collagen deposition detected lung histology confirmed increased hy droxyproline content dried lung tissue Acramoll W toxic effects vivo Interestingly multiple positive charges play important role toxic ity mechanism polycations irritant properties cytotoxicities decreased presence polyan ions42 Overall combined exposures textile dyes ny lon flock involved development diseases crosstalk investigated PVC PVC second commonly plastic mate rial worldwide numerous products credit cards keyboards flooring material food containers medical cannulae telephones highway sound barriers toys At end synthesis process material exist respirable dust inhalation result lung function impairment Epidemio logical surveys identified PVC dust etiologic agent dyspnea decreased pulmonary function appearance opacities chest radiograph43 particular type pulmonary fibrosis granulomatous reaction44 interstitial fibrosing pneumonia45 Electron micros copy revealed nonhomogenous material cytoplasm giant multinucleated cells andor alveolar macrophages identified PVC particles444647 Human alve olar macrophages engulfed PVC powder showed simi lar ultrastructural appearance46 It important note early PVC pneumoconiosis regress human cases48 Several studies PVC exposure animals conducted evidence fibroprolifera tion lung Rats guinea pigs monkeys ex posed inhalation 6 hours day 5 days week 22 months autopsies rats guinea pigs monkeys performed 12 22 months exposure respec tively PVC particles aggregated alveolar macrophages effects lung histology pulmonary function49 Hoet colleagues conducted detailed investigations effects PVC exposure vitro vivo Emulsion PVC particles mean diameter 2 mm exhibited moderate toxicity cultures different pulmonary cells rat human alveolar macrophages rat type II pneumocytes A549 cells type II cell type THP1 cells macrophagelike It cytotoxicity inflammatory potential PVC particles residual additives removal residual additives consider ably reduced toxic effects50 However vivo experi ments confirm conclusion vitro tox icity tests Male Wistar rats received single intratracheal instillation washed additivefree PVC particles As result exhibited pulmonary inflammation dam age similar silicaexposed rats 2 days Yoshida Ohnuma Horiuchi et al 13 90 days parameters returned control level minor histopathological lesions Interest ingly additivefree PVC particles caused neutrophil eosinophil influx original PVC particles taining residual detergents The washed additivefree PVC particles hydrophobic original PVC particles pulmonary eosinophilia induced unknown mechanism51 Repeated intratracheal instillation PVC particles 3 weeks increased number CD4 CD8 T cells BAL fluid compared orig inal PVC particles additivefree PVC particles tended induce changes endpoints including BAL eosinophilia52 observed single intratracheal instil lation study51 Experimental BAL eosinophilia apparently linked asthma reported epidemiological studies PVC5354 Together deposition PVC particles residual detergents alveolar macrophages subse quent immunoreactions contribute development PVCinduced pneumoconiosis DDAC DDAC C10H21NCH32C10H21Cl representative di alkyl quaternary ammonium compound QAC detergent wood preservatives disinfectant pathogens applications5558 DDAC formulations directly added water swimming pools spas hu midifiers treatment surfaces institutional commercial industrial residential settings fogging flooding immersion wiping mopping aerosol spray treat ment low highpressure spray treatments final spray concentrations ranging 05 26320 ppm59 The action DDAC cell membrane causes leakage intracellular molecules60 autolysis sub sequent death Escherichia coli Staphylococcus au reus61 Occupational exposure QACs including DDAC known cause contact dermatitis conjunc tivitis62 asthma6365 professionals working healthcare cleaning industries Although DDAC contaminate indoor hospital atmosphere disinfection process contaminate working atmospheres suspension aerosolization66 The health concerns expected exist veteri nary professionals DDAC useful disinfectant preventing entry spread infectious disease agents including enveloped nonenveloped viruses domes tic animals6768 Recently reported DDAC induces pulmonary injury fibrosis mice69 To knowledge report pulmonary fibroproliferative response topically applied DDAC In mice intratracheally stilled DDAC pulmonary cytotoxicity increase protein concentration LDH activity BAL fluid evident association inflammation confirmed expression monocyte chemotactic protein1 MCP 1 macrophage inflammatory protein MIP1a MIP1b regulated activation normal T cell expressed secreted RANTES BAL fluid These changes ac companied altered gene expression chemokine CC motif receptors Ccr1 Ccr2 Ccr3 Ccr5 lung Expression chemokines principally rived alveolar macrophages vitro cytotoxicity higher macrophages J7741 epithelial cells A549 isolated mouse lung fibroblast MLFlike cells Ohnuma et al unpublished data The cytotoxic inflammatory phases accompanied followed pulmonary remodeling fibrosis evident increase interstitial connective tissue fibroblasts myofibroblasts demonstrated Massons trichrome stain immunohistochemistry asmooth muscle actin aSMA mRNA expression type I procollagen69 Overall pulmonary injury peaked week single instillation DDAC lung fibroproliferation gradually profound week peaked second week subsequently reducing week Fig 1 The role TGFb BMP fibrogenesis cur rently investigated laboratories Limited toxicology information currently available DDAC5970 Similar DDAC benzalkonium chloride BAC mixture alkylbenzyldimethylammonium chlorides belonging QAC group widely disinfectant preservatives stabilizers Rats aspirated BAC following oral administration showed AIP71 Furthermore BAC inhalation caused strong inflammation irritant activity demonstrated increase lung weight high levels total protein LDH activity matrix metalloproteinase9 MMP9 TNFa MIP2 BAL fluid histopathological examinations carried out72 The mode action DDAC BAC hypothetically poses human health concerns particularly people unknowingly exposed QACs experi ence prolonged workplace exposure In current protocol similar sequence pulmonary changes occurring bleomycin fluorescein isothiocyanate FITCinduced lung injury7377 observed DDAC administration fibrotic response DDAC administration rapid weaker bleomycin FITC treatment This unique property pulmonary responses helpful better understanding pulmonary fibrotic diseases particularly promoting regenerating phases Molecular Targets Involved Pathogenesis Pulmonary Fibrosis Chemokines CCRs Inflammatory reactions involving influx par ticular cell types expressing cytokines chemokines cell surface molecules precede accompany pulmonary fibrosis nonspecific inflammatory processes end nonfibrous tissue repair78 Several cytokines che mokines receptors investigated gard contribution pathogenesis pulmonary 14 Profibrotic Environmental Cues Fig 1 DDAC induces inflammation fibroproliferation lungs Mice intratracheally instilled 001 DDAC vehicle control sacrificed day 7 13 20 treatment69 Lung tissue samples subjected histopathological examina tion Representative images lung tissues stained hematoxylin eosin AD Masson trichrome EH vehicle control A E DDACtreated mice day 7 BF 13 CG 20 DH Scale bar 50 µm fibrosis human animal models757982 Murine MCP1 known JE chemokine CC motif ligand 2 CCL2 considered homologous human CCL2 produced variety cells including en dothelial cells fibroblasts monocytes smooth muscle cells83 MCP1 receptor CCR2 involved fibrosis regulation profibrotic cytokine generation ECM formation8486 This supported fact CCR2 knockout mice FITC bleomycininduced pulmo nary fibrosis showed improvement fibrosis7487 The pro tective effect associated suppressed macrophage infiltration macrophagederived MMP production88 enhanced alveolar epithelial cell inhibition fibroblast proliferation89 CCR2 mediates neutrophil recruitment effects intravascular adherence subsequent transmigration90 Surprisingly MCP1 binds al veolar macrophages bone marrowderived fibro cytes express CCR291 Interestingly trans plant CCR2 bone marrow cells CCR2 recipients restored recruitment lung fibrocytes susceptibility FITCinduced fibrosis The study showed fibrocytes contribute fibrogenesis ways 1 fibro cytes directly contribute fibrosis secreting col lagen collagen secreted CCR2 fibrocytes exposed MCP1 greater secreted CCR2 fibrocytes 2 fibrocytes secrete TGFb1 CCR2mediated recruitment fibrocytes lung serve activate resident fibroblasts secretion TGFb1 3 fibrocytes differentiate effec tor fibroblasts Murine MCP5CCL12 homologous human CCL2 higher affinity activated macrophages MCP192 Moore et al 2006 proposed MCP5 MCP1 likely drive fi broproliferation mice interaction CCR293 Inconsistent Tsou et al 2007 demonstrated MCP1 MCP3 MCP2 MCP5 CCR2 agonists critical maintenance monocytes94 Thus contribution CCR2 agonists remains controversial MCPCCR2 represent link macrophagedominant phase subsequent remodeling phase CCR1 constitutively expressed monocytes neu Yoshida Ohnuma Horiuchi et al 15 trophils lymphocytes eosinophils interacts MIP1a RANTES MCP2 MCP38395 After bleo mycin challenge mice CCR1 mRNA levels CCR1 positive cells increased peaked day 7 paral leled expression MIP1a RANTES73 AntiCCR1 antibody inhibited inflammatory cell accumulation collagen deposition resulting dramatic improvement survival In contrast bleomycininduced increase trapulmonary macrophage fibrocyte numbers col lagen deposition attenuated MIP1a mice CCR1 mice77 CCR1 observed play limited role pulmonary granuloma formation granu loma size remained unchanged CCR1 mice com pared CCR1 mice challenged Sepharose beads coupled purified protein derivative Mycobacterium bovis soluble antigens derived Schistosoma man soni eggs96 However natural killer NK cell recruitment Th1 response expression IL2 IFNg duced Th2 response expression IL5 IL13 enhanced CCR1 mice comparison CCR1 mice Thus CCR1 critical immunemedi ated fibrotic disease supported fact airway remodeling goblet cell production subepi thelial fibrosis absent CCR1 mice chronic fungal allergic airway disease97 Rather CCR1 CCR5 receptor MIP1a critical regu lating fibrosis CCR5 mice showed attenuation collagen deposition macrophage infiltration induced bleomycin77 CCR3 highly expressed neutrophils eosino phils ligand eotaxin1CCL118395 Administration bleomycin induces marked pulmonary expression eotaxin1 CCR376 Eotaxin1 mice showed reduced pulmonary fibrosis associated decrease TGFb1 mRNA expression increased expression eo taxin1 eotaxin1expressing adenovirus enhanced bleomycininduced lung fibrosis Similar eotaxin1 mice treated neutralizing CCR3 antibodies showed reduced pulmonary fibrosis eosinophilia neutro philia TGFb1 mRNA expression CCR4 selective marker Th2 lymphocytes expressed dendritic cells NK cells monocytes thymus activationregulated chemokine TARC CCL17 macrophagederived chemokine MDCCCL22 highaffinity ligands highpotency agonists CCR4839598 The mRNA protein expressions TARC MDC elevated lung tissues bleo mycin treatment related alveolar expression CCR499 Neutralization TARC MDC led reduction collagen deposition BAL leukocytes cluding CD4 T cells CD8 T cells NK cells macrophages neutrophils TARC expressed alveolar epithelial cells lung tissues bleomycintreated mice hu man patients IPF These data support results experiment conducted CCR4 mice protected bleomycininduced lethal inflammatory fibrotic responses evidence reduction TARC MDC levels observed lung homogenates100 A major tribution protective effect regulatory role CCR4 determining phenotype macrophages dur ing acute inflammatory phase switching classically activated M1 macrophages type1 polarization induced Th1 signals IFNg expression alternatively acti vated M2 macrophages type2 polarization induced Th2 signals IL4 IL13 expression In presence CCR4 TARC MDC promoted tissue injury induction M1 macrophage phenotype increased nitric oxide synthase 2 NOS2 decreased arginase 1 expression absence CCR4 M2 macrophage activa tion occurred suppression NOS2 increased expression arginase 1 inflammatory zone 1 FIZZ1 favoring upregulation decoy receptor D6 attenuates inflammation tissue injury inter nalizing degrading chemokines Thus appears alterations M1M2 marker expression confined early inflammatory stage establishment fibrotic process necessarily associated M2 po larization101 Furthermore reduction arginase 1 lung epithelial cells enhanced levels NO metabolites S nitrosylated proteins resulted increased TNFa li popolysaccharide LPSstimulated nuclear factorkB NF kB DNA binding102 Coculture FIZZ1expressing type II alveolar epithelial cells fibroblasts stimulates aSMA type I collagen expression independent TGFb103 dependent NotchJagged 1104 The imbalance arginase 1 NOS2 association induction FIZZ1 contribute fibrogenesis depending stage inflam mation specific cell types CCR7 expressed T B cells plays im portant role T cell dendritic cell trafficking associ ation ligands EpsteinBarrinduced 1 EBI1ligand chemokine ELCCCL19 secondary lymphoidtissue chemokine SLCCCL218398 CCR7 expression raised severe form IIP UIP localized focal areas sisting activated resident fibroblasts myofi broblasts bone marrowderived fibrocytes105 This supported Pierce et al 2007 showed CCR7 expressed primary IPFUIP fibroblasts normal fibroblasts IPFUIP fibroblasts showed migration pro liferation response CCR7 activation SLC ELC SLCmediated CCR7 activation lim ited extracellular signalregulated kinase ERK12 90kDa ribosomal S6 kinase p90RSK pathways p38 mitogenactivated protein kinase MAPK c Jun Nterminal kinase JNK pathways activated SLC106 The investigators adopted unusual technique clarify role SLCCCR7 axis elegantly IPFUIP fibroblasts NSIP fibroblasts normal fibroblasts intravenously injected severe combined immunodefi ciency SCID mice lacking adaptive innate immune features Interestingly mice IPFUIP fibroblasts showed patchy interstitial fibrosis NSIP fi 16 Profibrotic Environmental Cues broblasts showed diffuse interstitial fibrosis increased hydroxyproline content cases The inject ed normal fibroblasts induce interstitial remodeling Neutralization SLC CCR7 attenuated pulmonary fibro sis mice received type fibroblasts However delayed onset pulmonary remodeling noted 35 days intravenous injection remains clarified Similarly Trujillo et al 2010 showed CCR7 mice protected bleomycininduced pulmonary fibro sis effect related early increase lung CD4 T cells late increase CD4CD25FoxP3 Tregs consistent increased IL2 expression107 indicating CCR7independent Tregs expansion novel therapeu tic target pulmonary fibrosis Tregs T cells present lungs patients pulmo nary fibrosis variety causes play pivotal role fibrotic process CD4 T cells abundant lung granulomatous lung diseases IPF sarcoidosis berylliosis1013108 In fact CD4 T cells IPF patients characteristics typical cellmediated pathologic sponses including augmented effector functions produc tion TGFb1 IL10 TNFa provision facultative help immunoglobulin G IgG autoantibody production oligoclonal expansions proliferations driven tigen present diseased tissues109 Most previous studies investigated T cells emerging novel sub populations naturally occurring adaptive Tregs center stage crucial immunoregulatory cells capable suppressing Th1 Th2mediated adaptive immune responses cell contactdependent fashion di rectly acting antigenpresenting cells110 Since transcription factor Foxp3 shown selectively expressed Tregs humans mice Foxp3 mRNA rep resents specific marker cell surface molecules CD25 cytotoxic T lymphocyteassociated antigen 4 CTLA4 glucocorticoidinduced TNF receptor GITR111114 In CBD berylliumsensitized patients small pop ulation BAL CD4 T cells retained CD27 expression CD4CD27 T cells contained FoxP3expressing naturally occurring Treg subset increasing T cell expansion vast majority CD4 T cells lost surface CD27 expression inversely correlated lung inflamma tion patients115 The number CD4CD25FOXP3 Tregs activities demonstrated Th1 Th2cy tokine expression reduced BAL peripheral blood patients IPF compared healthy volunteers patients IPF defective function BAL Tregs highly correlated parameters disease severity determined pulmonary function tests116 Furthermore downregulation CD28 duces FoxP3 generates CD4CD25 Tregs evident IPF patients patients demonstrated infiltrations CD4CD28null T cells lung tissues positive cor relation presence cells indication lung transplantation death year117 Thus data suggested Tregs play pivotal role pulmonary fibrosis additional studies extensively addressing Treg interactions cellular soluble factors animal models human patients required reported Treg depletion accelerates vitro granuloma growth mononuclear cell cultures healthy controls patients active sarcoidosis118 TGFb BMP signaling TGFb1 ability induce expression ECM proteins mesenchymal cells119 Cellular TGFb1 mRNA levels higher cellular TGFb2 TGF b3 mRNA levels IPF patients120 bleomycintreated mice121 However TGFb2 TGFb3 potential vitro fibrogenic activity higher vitro fibrogenic activity TGFb1122 Signaling TGFb family members occurs TGFb type I type II receptors TGFbRI TGFbRII respectively119123124 Upon phosphorylation activated TGFbRIactivin recep torlike kinase5 ALK5 TGFbactivated Smad2Smad3 forms heteromeric complex Smad4 trans located nucleus functions transcription factor Smad3 particular critical importance development fibrosis124125 loss Smad3 greatly attenuated histopathological fibrotic responses bleomy cin126 active TGFb1expressing adenovirus127 mouse lung Active TGFb1 major cytokine stimu lates transcription Col1a2 gene determined binding Smad3Smad4 complex ciselement TGF bresponsive element TbRE proximal promoter gion128 It important note repression collagen gene expression critical pulmonary disease therapy lately complex underlying mechanisms proposed Xu et al 2006 2007 methylationmediated repression mediated interaction regula tory factor Xbox 1 RFX1 histone deacetylase 1 HDAC1 TATA box IFNgmediated repression mediated interaction RFX5 class II trans activator HDAC2 peroxisome proliferatoractivated receptor g CCAAT TATTA boxes129130 Lin et al 2006 identified protein phosphatase 1A PP1APP2Ca Smad2Smad3 SXS motifspecific phosphatase inhibits Smad2Smad3 phosphorylation131 Interestingly phosphatase tensin homolog PTEN deleted chro mosome 10 plays negative role TGFb pathway forming complex PP1APP2Ca132 A lipid mediator sphingosine 1phosphate S1P mimics TGFbinduced cell responses crossactivation Smad signaling133 Rho signaling134 cascades dihydrosphingosine 1phosphate dS1P plays opposite role regula tion TGFb signaling stimulating phosphorylation PTEN subsequent translocation nucleus132 Thus repression collagen gene expression negative Yoshida Ohnuma Horiuchi et al 17 Fig 2 Proposed concept toxicological pulmonary granuloma fibrosis lung diseases induced response environmental cues Chemicals potential function antigens irritants alveolar macrophages dendritic cells andor epithelial cells Antigens presented T cells APCs inducing Th1type inflammation expressing TNFa IFNg IL2 recruiting CD4 CD8 T cells contribute formation giant epithelioid cells Only Tregs affected humans animals compared controls subsequently disturbing Th1Th2 balance On hand cytotoxicity irritants induces inflammation association expression chemokines MIP1a MCP1 MCP3 MCP5 eotaxin1 TARC MDC ELC SLC recruitment macrophages PMN lymphocytes T cellsB cells followed proliferation fibroblasts myo fibroblasts Circulating fibrocytes derived bone marrow contribute fibrotic disorders lung Profibrotic antifibrotic signaling regulated TGFbBMPgremlin PP1APTEN signaling APCs antigenpresenting cells Th1 T helper 1 TNFa tumor necrosis factora IFNg interferong IL2 interleukin2 Tregs regulatory T cells Th2 T helper 2 MIP macrophage inflammatory protein MCP1 monocyte chemotactic protein1 TARC thymus activationregulated chemokine MDC macrophage derived chemokine ELC EpsteinBarrinduced 1 EBI1ligand chemokine SLC secondary lymphoidtis sue chemokine PMN polymorphonuclear neutrophils TGFb transforming growth factorb BMP bone morphogenetic protein PP1A protein phosphatase 1A PTEN phosphatase tensin homolog regulation TGFbSmad signaling formation PP1APP2CaPTEN complex probably mediated dS1P open possibilities control progression pul monary fibrosis Further TGFb terminates induction target genes induction Smad7 competes Smad2 Smad3 binding TGFbRI125 inhibits receptoractivated Smad2 phosphorylation135 recruits E3 ubiquitin ligases Smurf1 Smurf2 Nedd42 WW domaincontaining protein 1 WWP1Tiul1 TGFbRI Smads causing degradation136 specifically binds Smadresponsive element Mad homol ogy 2 MH2 domain disrupts formation TGFb induced functional SmadDNA complex137 As expected decrease expression Smad7 observed bleomycin instillation rats contrast persistent crease phosphorylation nuclear localization Smad2Smad3138 The groups compared levels phosphorylated Smad3 Smad7 isolated fibroblasts lungs control bleomycintreated rats normal conditions TGFb treatment139 The basal levels phosphorylated Smad3 higher mal lung fibroblasts bleomycintreated lung fibro blasts basal levels Smad7 comparable After TGFb treatment levels phosphorylated Smad3 Smad7 mRNA increased treated normal cells protein level Smad7 increased normal lung fibroblasts compared bleomycin 18 Profibrotic Environmental Cues treated lung fibroblasts The investigators concluded inadequate response TGFb consequent imbalance levels Smad7 phosphorylated Smad3 contribute fibrotic phenotype characteristic activated fibroblasts In fact bleomycininduced collagen deposition phosphorylation Smad3 prevented intratracheal injection recombinant adenovirus carrying mouse Smad7 cDNA140 Intriguingly inhibition TGFb2 release IFNg141 myofibroblast differentia tion hepatocyte growth factor HGF142 report ed dependent Smad7 Overall overexpression Smad7 therapeutic target IIPs BMPs member TGFb family vestigated pulmonary vascular disorders especially pul monary hypertension linked mutations BMP receptor II gene123 expression BMP2 BMP4 BMP2 expression increased proinflamma tory stimuli induces endothelial dysfunction oxidative stress endothelial activation including increased adhe sion monocyte cell line143 BMP4 promotes migration vascular smooth muscle cells possibly contributing vascular remodeling medial wall thickening mus cularization vessel walls144 Lately role BMPs par ticularly BMP7 BMP4 gremlin pulmo nary fibrosis investigated BMP7 known act antagonist TGFb1dependent fibrogenic activity mouse pulmonary myofibroblasts inducing inhibitor differentiation 2145 important myoepithelial cell marker epithelialmesenchymal transition146147 However role BMP7 fibrosis remains controver sial BMP7 treatment significantly reduced hy droxyproline content asbestostreated mice148 bleomycintreated mice149 No alterations BMP4 levels reported lung samples IPF patients IPF fibroblasts responsive exogenous BMP4 inhibits growth induces apoptosis myofibro blasts120 However BMP4 BMP7 accurately regulate fibrogenesis different ways BMP4 BMP7 duces TGFb1induced ECM production BMP7 BMP4 inhibits TGFb1induced myofibroblast trans formation normal human lung fibroblasts150 On hand TGFb1 induces expression BMP inhibitor gremlin A549 lung epithelial cells IPF fibroblasts lung samples high levels gremlin mRNA protein120148 Pulmonary gremlin mRNA levels upregulated asbestostreated mice148 Increased gremlin level decrease BMP4mediated myofibroblast apoptosis increase TGFb signaling suppression BMP signaling This concept supported evidence latent TGFbbinding protein4 fibroblasts ex hibited reduced activation TGFb increased ex pression BMP4 decreased expression gremlin151 Thus profibrotic antifibrotic signaling regulated TGFb BMPs role gremlin disrupting balance mediators provides complex feedback loop coordinating fibrogenesis152 Conclusion The mechanism cytotoxicity inflamma tion cause fibrosis lung response environmen tal cues fully understood In pulmonary fibrotic conditions cytotoxicity inflammation repair dysregulated imbalance production chemokines cytokines growth factors pulmonary wound repair extremely dynamic process intersecting immunology structural biology airway physiology153 When cyto toxic effect minimal selflimiting repair pro ceed restore normal structure injury extensive tissue repair result scarring fibrosis154 The significance new discoveries derstanding pathogenesis diseases potential molecular targets involved advancing interfering fibrogenesis continues evaluated vivo analy ses animal models substituting patients ILDs DPLDs155 Important advances identify ing molecules able inhibit induce lung granu lomas fibrosis including TGFb BMP signaling chemokines receptors relation reduction Tregs Fig 2 Evidence toxicological approaches expected explore new aspects pulmonary diseases Exposure beryllium causes Th1 cytokine TNFa IFN g IL2dominant granulomatous process share features sarcoidosis frequent disorder similar pathological features156157 Discovering role Tregs CBD provides new insights mechanism development granulomatous lesions On hand nongranulomatous fibrosis nylon flock exposed individuals textile paint exposure experimental data limited 2010 PVC known etiological agent pneumoconiosis including granulomatous nongranulomatous fibrosis lung cancer hepatic angiosarcoma leukemialym phoma158 QACs including DDAC cause pulmonary diseases asthma fibrosis shown etiological research6365 experimental study69 Because types ILDsDPLDs Table 1 note caution pathological characteristics human animal cases References 1 Greaves P Respiratory tract In Histopathology Preclini cal Toxicity Studies Interpretation Relevance Drug Safety Evaluation Third Edition Elsevier Inc Oxford UK 215269 2007 2 King Jr TE Clinical advances diagnosis therapy interstitial lung diseases Am J Respir Crit Care Med 172 268279 2005Medline CrossRef 3 American Thoracic Society European Respiratory Society American Thoracic SocietyEuropean Respiratory Society International Multidisciplinary Consensus Classification Idiopathic Interstitial Pneumonias This joint statement Yoshida Ohnuma Horiuchi et al 19 American Thoracic Society ATS European Respiratory Society ERS adopted ATS board directors June 2001 ERS Executive Commit tee June 2001 Am J Respir Crit Care Med 165 277304 2002Medline 4 Maher TM Wells AU Laurent GJ Idiopathic pulmo nary fibrosis multiple causes multiple mechanisms Eur Respir J 30 835839 2007Medline CrossRef 5 Visscher DW Myers JL Histologic spectrum id iopathic interstitial pneumonias Proc Am Thorac Soc 3 322329 2006Medline CrossRef 6 Taskar VS Coultas DB Is idiopathic pulmonary fi brosis environmental disease Proc Am Thorac Soc 3 293298 2006Medline CrossRef 7 Camus P Fanton A Bonniaud P Camus C Foucher P Interstitial lung disease induced drugs radiation Respiration 71 301326 2004Medline CrossRef 8 Kelleher P Pacheco K Newman LS Inorganic dust pneumonias metalrelated parenchymal disorders En viron Health Perspect 108Suppl 4 685696 2000Med line CrossRef 9 Cooper RG Harrison AP The uses adverse effects beryllium health Indian J Occup Environ Med 13 6576 2009Medline CrossRef 10 Fontenot AP Canavera SJ Gharavi L Newman LS Kotzin BL Target organ localization memory CD4 T cells patients chronic beryllium disease J Clin In vest 110 14731482 2002Medline 11 Cummings KJ Stefaniak AB Virji MA Kreiss K A reconsideration acute beryllium disease Environ Health Perspect 117 12501256 2009Medline 12 Bill JR Mack DG Falta MT Maier LA Sullivan AK Joslin FG Martin AK Freed BM Kotzin BL Fontenot AP Beryllium presentation CD4 T cells dependent single amino acid residue MHC class II bchain J Immunol 175 70297037 2005Medline 13 Fontenot AP Maier LA Genetic susceptibility im munemediated destruction berylliuminduced disease Trends Immunol 26 543549 2005Medline CrossRef 14 Dai S Murphy GA Crawford F Mack DG Falta MT Mar rack P Kappler JW Fontenot AP Crystal structure HLADP2 implications chronic beryllium disease Proc Natl Acad Sci USA 107 74257430 2010Medline CrossRef 15 TarantinoHutchison LM Sorrentino C Nadas A Zhu Y Rubin EM Tinkle SS Weston A Gordon T Genetic determinants sensitivity beryllium mice J Immu notoxicol 6 130135 2009Medline CrossRef 16 Newman LS Lloyd J Daniloff E The natural history beryllium sensitization chronic beryllium disease En viron Health Perspect 104Suppl 5 937943 1996Med line CrossRef 17 Nikula KJ Swafford DS Hoover MD Tohulka MD Finch GL Chronic granulomatous pneumonia lympho cytic responses induced inhaled beryllium metal AJ C3HHeJ mice Toxicol Pathol 25 212 1997Med line CrossRef 18 Tinkle SS Kittle LA Schumacher BA Newman LS Beryllium induces IL2 IFNg berylliosis J Immu nol 158 518526 1997Medline 19 Sawyer RT Fontenot AP Barnes TA Parsons CE Tooker BC Maier LA Gillespie MM Gottschall EB Silveira L Hagman J Newman LS Berylliuminduced TNFa production transcriptiondependent chronic beryl lium disease Am J Respir Cell Mol Biol 36 191200 2007Medline CrossRef 20 Salehi F Zayed J Audusseau S Muller C Truchon G Pla mondon P Lespérance G Chevalier G Mazer B Im munological responses C3HHeJ mice following nose inhalation exposure different sizes beryllium metal particles J Appl Toxicol 29 6168 2009Medline CrossRef 21 Palmer BE Mack DG Martin AK Gillespie M Mroz MM Maier LA Fontenot AP Upregulation programmed death1 expression berylliumspecific CD4 T cells chronic beryllium disease J Immunol 180 27042712 2008Medline 22 Dobis DR Sawyer RT Gillespie MM Huang J Newman LS Maier LA Day BJ Modulation lymphocyte pro liferation antioxidants chronic beryllium disease Am J Respir Crit Care Med 177 10021011 2008Medline CrossRef 23 Comhair SA Lewis MJ Bhathena PR Hammel JP Er zurum SC Increased glutathione glutathione peroxi dase lungs individuals chronic beryllium disease Am J Respir Crit Care Med 159 18241829 1999Med line 24 Kokturk N Sabag M Stark M Grief J Fireman E High extracellular induced sputum heme oxygenase1 sarcoid osis chronic beryllium disease Eur J Clin Invest 39 584590 2009Medline CrossRef 25 Inoue Y King Jr TE Tinkle SS Dockstader K New man LS Human mast cell basic fibroblast growth factor pulmonary fibrotic disorders Am J Pathol 149 20372054 1996Medline 26 Lehnert NM Gary RK Marrone BL Lehnert BE In hibition normal human lung fibroblast growth beryl lium Toxicology 160 119127 2001Medline CrossRef 27 Coates SS Lehnert BE Sharma S Kindell SM Gary RK Beryllium induces premature senescence human fibroblasts J Pharmacol Exp Ther 322 7079 2007Med line CrossRef 28 Keshava N Zhou G Spruill M Ensell M Ong TM Carcinogenic potential genomic instability beryl lium sulfate BALBc3T3 cells Mol Cell Biochem 222 6976 2001Medline CrossRef 29 Jonth AC Silveira L Fingerlin TE Sato H Luby JC Welsh KI Rose CS Newman LS du Bois RM Maier LA AC CESS Group TGFb1 variants chronic beryllium disease sarcoidosis J Immunol 179 42554262 2007Med line 30 Kern DG Kuhn 3rd C Ely EW Pransky GS Mello CJ Frai AE Müller J Flock workers lung broadening spectrum clinicopathology narrowing spectrum 20 Profibrotic Environmental Cues suspected etiologies Chest 117 251259 2000Medline CrossRef 31 Eschenbacher WL Kreiss K Lougheed MD Pransky GS Day B Castellan RM Nylon flockassociated intersti tial lung disease Am J Respir Crit Care Med 159 2003 2008 1999Medline 32 Boag AH Colby TV Fraire AE Kuhn 3rd C Roggli VL Travis WD Vallyathan V The pathology interstitial lung disease nylon flock workers Am J Surg Pathol 23 15391545 1999Medline CrossRef 33 Warheit DB Hart GA Hesterberg TW Collins JJ Dyer WM Swaen GM Castranova V Soiefer AI Kennedy Jr GL Potential pulmonary effects manmade organic fiber MMOF dusts Crit Rev Toxicol 31 697736 2001Med line CrossRef 34 Porter DW Castranova V Robinson VA Hubbs AF Mercer RR Scabilloni J Goldsmith T SchweglerBerry D Battelli L Washko R Burkhart J Piacitelli C Whitmer M Jones W Acute inflammatory reaction rats intratra cheal instillation material collected nylon flocking plant J Toxicol Environ Health A 57 2545 1999Med line CrossRef 35 Warheit DB Webb TR Reed KL Hansen JF Kennedy Jr GL Fourweek inhalation toxicity study rats ny lon respirable fibers rapid lung clearance Toxicology 192 189210 2003Medline CrossRef 36 Ghio AJ Funkhouser W Pugh CB Winters S Stonehuerner JG Mahar AM Roggli VL Pulmonary fibrosis fer ruginous bodies associated exposure synthetic fibers Toxicol Pathol 34 723729 2006Medline CrossRef 37 Moya C Antó JM Taylor AJ Outbreak organizing pneumonia textile printing sprayers Collaborative Group Study Toxicity Textile Aerographic Factories Lancet 344 498502 1994Medline CrossRef 38 Romero S Hernández L Gil J Aranda I Martín C SanchezPayá J Organizing pneumonia textile printing workers clinical description Eur Respir J 11 265271 1998Medline CrossRef 39 Solé A Cordero PJ Morales P Martínez ME Vera F Moya C Epidemic outbreak interstitial lung disease aerographics textile workersthe Ardystil syndrome year follow Thorax 51 9495 1996Medline CrossRef 40 Hoet PH Gilissen LP Leyva M Nemery B In vitro cytotoxicity textile paint components linked Ar dystil syndrome Toxicol Sci 52 209216 1999Medline CrossRef 41 Clottens FL Verbeken EK Demedts M Nemery B Pulmonary toxicity components textile paint linked Ardystil syndrome intratracheal administration hamsters Occup Environ Med 54 376387 1997Med line CrossRef 42 Hoet PH Gilissen L Nemery B Polyanions protect vitro pulmonary toxicity polycationic paint components associated Ardystil syndrome Toxicol Appl Pharmacol 175 184190 2001Medline CrossRef 43 Soutar CA Copland LH Thornley PE Hurley JF Ottery J Adams WG Bennett B Epidemiological study spiratory disease workers exposed polyvinylchloride dust Thorax 35 644652 1980Medline CrossRef 44 Lilis R Review pulmonary effects polyvinyl chloride vinyl chloride exposure Environ Health Perspect 41 167169 1981Medline CrossRef 45 Cordasco EM Demeter SL Kerkay J Van Ordstrand HS Lucas EV Chen T Golish JA Pulmonary manifesta tions vinyl polyvinyl chloride interstitial lung dis ease Newer aspects Chest 78 828834 1980Medline CrossRef 46 Arnaud A Pommier Santi PP Garbe L Payan H Charpin J Polyvinyl chloride pneumoconiosis Thorax 33 1925 1978Medline CrossRef 47 AnttiPoika M Nordman H Nickels J Keskinen H Vil janen A Lung disease exposure polyvinyl chloride dust Thorax 41 566567 1986Medline CrossRef 48 White NW Ehrlich RI Regression polyvinylchloride polymer pneumoconiosis Thorax 52 748749 1997Med line CrossRef 49 Groth DH Lynch DW Moorman WJ Stettler LE Lewis TR Wagner WD Kommineni C Pneumoconiosis animals exposed polyvinyl chloride dust Environ Health Perspect 41 7381 1981Medline CrossRef 50 Xu H Dinsdale D Nemery B Hoet PH Role residual additives cytotoxicity cytokine release caused polyvinyl chloride particles pulmonary cell cultures Toxicol Sci 72 92102 2003Medline CrossRef 51 Xu H Verbeken E Vanhooren HM Nemery B Hoet PH Pulmonary toxicity polyvinyl chloride particles af ter single intratracheal instillation rats Time course comparison silica Toxicol Appl Pharmacol 194 111121 2004Medline CrossRef 52 Xu H Vanhooren HM Verbeken E Yu L Lin Y Nemery B Hoet PH Pulmonary toxicity polyvinyl chloride particles repeated intratracheal instillations rats Elevated CD4CD8 lymphocyte ratio bronchoalveolar lavage Toxicol Appl Pharmacol 194 122131 2004Med line CrossRef 53 Gannon PF Burge PS Benfield GF Occupational asth ma polyethylene shrink wrapping paper wrappers asthma Thorax 47 759 1992Medline CrossRef 54 Tuomainen A Stark H Seuri M Hirvonen MR Linnainmaa M Sieppi A Tukiainen H Experimental PVC mate rial challenge subjects occupational PVC exposure Environ Health Perspect 114 14091413 2006Medline CrossRef 55 Skaliy P Thompson TA Gorman GW Morris GK McEach ern HV Mackel DC Laboratory studies disinfec tants Legionella pneumophila Appl Environ Mi crobiol 40 697700 1980Medline 56 Kanazawa A Ikeda T Endo T Synthesis antimicro bial activity dimethyl trimethylsubstituted phos phonium salts alkyl chains lengths Antimi crob Agents Chemother 38 945952 1994Medline 57 Dickey P Guidelines selecting wood preservatives For San Francisco Department Environment Sep Yoshida Ohnuma Horiuchi et al 21 tember 9 2003 The guidelines available httpwww sfenvironmentorgdownloadslibrarypreservativespdf 58 Walsh SE Maillard JY Russell AD Catrenich CE Char bonneau DL Bartolo RG Activity mechanisms action selected biocidal agents Grampositive negative bacteria J Appl Microbiol 94 240247 2003Medline CrossRef 59 United States Environmental Protection Agency Reregis tration eligibility decision aliphatic alkyl quaternaries DDAC August 2006 The guidelines available httpwwwepagovoppsrrd1REDsddac_redpdf 60 Yoshimatsu T Hiyama K Mechanism action didecyldimethylammonium chloride DDAC Esch erichia coil morphological changes cells Biocon trol Sci 12 9399 2007Medline 61 Ioannou CJ Hanlon GW Denyer SP Action disin fectant quaternary ammonium compounds Staphy lococcus aureus Antimicrob Agents Chemother 51 296 306 2007Medline CrossRef 62 Dejobert Y Martin P Piette F Thomas P Bergoend H Contact dermatitis didecyldimethylammonium chlo ride bisaminopropyllauryl amine detergentdis infectant hospital Contact Dermatitis 37 9596 1997Medline CrossRef 63 Bernstein JA Stauder T Bernstein DI Bernstein IL A combined respiratory cutaneous hypersensitivity syndrome induced work exposure quaternary amines J Allergy Clin Immunol 94 257259 1994Medline CrossRef 64 Burge PS Richardson MN Occupational asthma indirect exposure lauryl dimethyl benzyl ammoni um chloride floor cleaner Thorax 49 842843 1994Medline CrossRef 65 Purohit A KopferschmittKubler MC Moreau C Popin E Blaumeiser M Pauli G Quaternary ammonium com pounds occupational asthma Int Arch Occup Environ Health 73 423427 2000Medline CrossRef 66 Vincent G KopferschmittKubler MC Mirabel P Pauli G Millet M Sampling analysis quaternary ammo nium compounds QACs traces indoor atmosphere En viron Monit Assess 133 2530 2007Medline CrossRef 67 Shirai J Kanno T Inoue T Mitsubayashi S Seki R Effects quaternary ammonium compounds 01 dium hydroxide swine vesicular disease virus J Vet Med Sci 59 323328 1997Medline CrossRef 68 Shirai J Kanno T Tsuchiya Y Mitsubayashi S Seki R Effects chlorine iodine quaternary ammonium compound disinfectants exotic disease viruses J Vet Med Sci 62 8592 2000Medline CrossRef 69 Ohnuma A Yoshida T Tajima H Fukuyama T Hayashi K Yamaguchi S Ohtsuka R Sasaki J Fukumori J Tomita M Kojima S Takahashi N Takeuchi Y Kuwahara M Takeda M Kosaka T Nakashima N Harada T Didecyldi methylammonium chloride induces pulmonary inflamma tion fibrosis mice Exp Toxicol Pathol 62 643651 2010Medline CrossRef 70 BIBRA Toxicity Profile Didecyldimethylammonium Chlo ride BIBRA International Ltd Carshalton UK 1990 71 Xue Y Hieda Y Saito Y Nomura T Fujihara J Takayama K Kimura K Takeshita H Distribution disposition benzalkonium chloride following routes ad ministration rats Toxicol Lett 148 113123 2004Med line CrossRef 72 Swiercz R Hałatek T Wasowicz W Kur B Grzelińska Z Majcherek W Pulmonary irritation inhalation ex posure benzalkonium chloride rats Int J Occup Med Environ Health 21 157163 2008Medline CrossRef 73 Tokuda A Itakura M Onai N Kimura H Kuriyama T Matsushima K Pivotal role CCR1positive leukocytes bleomycininduced lung fibrosis mice J Immunol 164 27452751 2001Medline 74 Moore BB Paine 3rd R Christensen PJ Moore TA Sitter ding S Ngan R Wilke CA Kuziel WA Toews GB Protection pulmonary fibrosis absence CCR2 signaling J Immunol 167 43684377 2001Medline 75 Yara S Kawakami K Kudeken N Tohyama M Teruya K Chinen T Awaya A Saito A FTS reduces bleomycin induced cytokine chemokine production inhibits pulmonary fibrosis mice Clin Exp Immunol 124 7785 2001Medline CrossRef 76 Huaux F GharaeeKermani M Liu T Morel V McGarry B Ullenbruch M Kunkel SL Wang J Xing Z Phan SH Role Eotaxin1 CCL11 CC chemokine receptor 3 CCR3 bleomycininduced lung injury fibrosis Am J Pathol 167 14851496 2005Medline 77 Ishida Y Kimura A Kondo T Hayashi T Ueno M Takaku ra N Matsushima K Mukaida N Essential roles CC chemokine ligand 3CC chemokine receptor 5 axis bleomycininduced pulmonary fibrosis regulation macrophage fibrocyte infiltration Am J Pathol 170 843854 2007Medline CrossRef 78 Luzina IG Todd NW Iacono AT Atamas SP Roles T lymphocytes pulmonary fibrosis J Leukoc Biol 83 237244 2008Medline CrossRef 79 Hasegawa M Sato S Takehara K Augmented pro duction chemokines monocyte chemotactic protein1 MCP1 macrophage inflammatory protein1a MIP1a MIP1b patients systemic sclerosis MCP1 MIP1a involved development pulmonary fibrosis Clin Exp Immunol 117 159165 1999Medline CrossRef 80 Smith RE Strieter RM Zhang K Phan SH Standiford TJ Lukacs NW Kunkel SL A role CC chemo kines fibrotic lung disease J Leukoc Biol 57 782787 1995Medline 81 Emad A Emad V Elevated levels MCP1 MIPa MIP1b bronchoalveolar lavage BAL fluid pa tients mustard gasinduced pulmonary fibrosis Toxi cology 240 6069 2007Medline CrossRef 82 Shinoda H Tasaka S Fujishima S Yamasawa W Miyamoto K Nakano Y Kamata H Hasegawa N Ishizaka A Ele vated CC chemokine level bronchoalveolar lavage fluid predictive poor outcome idiopathic pulmonary fibro sis Respiration 78 285292 2009Medline CrossRef 22 Profibrotic Environmental Cues 83 Deshmane SL Kremlev S Amini S Sawaya BE Monocyte chemoattractant protein1 MCP1 view J Interferon Cytokine Res 29 313326 2009Med line CrossRef 84 GharaeeKermani M Denholm EM Phan SH Co stimulation fibroblast collagen transforming growth factor b1 gene expression monocyte chemoattractant protein1 specific receptors J Biol Chem 271 17779 17784 1996Medline CrossRef 85 Yamamoto T Eckes B Mauch C Hartmann K Krieg T Monocyte chemoattractant protein1 enhances gene expres sion synthesis matrix metalloproteinase1 human fibroblasts autocrine IL1a loop J Immunol 164 61746179 2000Medline 86 Agostini C Gurrieri C Chemokinecytokine cocktail idiopathic pulmonary fibrosis Proc Am Thorac Soc 3 357363 2006Medline CrossRef 87 GharaeeKermani M McCullumsmith RE Charo IF Kun kel SL Phan SH CCchemokine receptor 2 required bleomycininduced pulmonary fibrosis Cytokine 24 266276 2003Medline CrossRef 88 Okuma T Terasaki Y Kaikita K Kobayashi H Kuziel WA Kawasuji M Takeya M CC chemokine receptor 2 CCR2 deficiency improves bleomycininduced pulmo nary fibrosis attenuation macrophage infiltration production macrophagederived matrix metallopro teinases J Pathol 204 594604 2004Medline Cross Ref 89 Moore BB PetersGolden M Christensen PJ Lama V Kuz iel WA Paine 3rd R Toews GB Alveolar epithelial cell inhibition fibroblast proliferation regulated MCP1 CCR2 mediated PGE2 Am J Physiol Lung Cell Mol Physiol 284 L342L349 2003Medline 90 Reichel CA Khandoga A Anders HJ Schlöndorff D Luck ow B Krombach F Chemokine receptors Ccr1 Ccr2 Ccr5 mediate neutrophil migration postischemic tis sue J Leukoc Biol 79 114122 2006Medline CrossRef 91 Moore BB Kolodsick JE Thannickal VJ Cooke K Moore TA Hogaboam C Wilke CA Toews GB CCR2me diated recruitment fibrocytes alveolar space fibrotic injury Am J Pathol 166 675684 2005Medline 92 Sarafi MN GarciaZepeda EA MacLean JA Charo IF Luster AD Murine monocyte chemoattractant protein MCP5 novel CC chemokine structural functional homologue human MCP1 J Exp Med 185 99109 1997Medline CrossRef 93 Moore BB Murray L Das A Wilke CA Herrygers AB Toews GB The role CCL12 recruitment fibrocytes lung fibrosis Am J Respir Cell Mol Biol 35 175181 2006Medline CrossRef 94 Tsou CL Peters W Si Y Slaymaker S Aslanian AM Weis berg SP Mack M Charo IF Critical roles CCR2 MCP3 monocyte mobilization bone marrow recruitment inflammatory sites J Clin Invest 117 902909 2007Medline CrossRef 95 Yoshida T Tuder RM Pathobiology cigarette smoke induced chronic obstructive pulmonary disease Physiol Rev 87 10471082 2007Medline CrossRef 96 Shang X Qiu B Frait KA Hu JS Sonstein J Curtis JL Lu B Gerard C Chensue SW Chemokine receptor 1 knockout abrogates natural killer cell recruitment im pairs type1 cytokines lymphoid tissue pulmo nary granuloma formation Am J Pathol 157 20552063 2000Medline 97 Blease K Mehrad B Standiford TJ Lukacs NW Kunkel SL Chensue SW Lu B Gerard CJ Hogaboam CM Air way remodeling absent CCR1 mice chronic fungal allergic airway disease J Immunol 165 15641572 2000Medline 98 Horuk R Chemokine receptors Cytokine Growth Factor Rev 12 313335 2001Medline CrossRef 99 Belperio JA Dy M Murray L Burdick MD Xue YY Stri eter RM Keane MP The role Th2 CC chemo kine ligand CCL17 pulmonary fibrosis J Immunol 173 46924698 2004Medline 100 Trujillo G OConnor EC Kunkel SL Hogaboam CM A novel mechanism CCR4 regulation macro phage activation bleomycininduced pulmonary fibrosis Am J Pathol 172 12091221 2008Medline CrossRef 101 Misson P van den Brûle S Barbarin V Lison D Huaux F Markers macrophage differentiation experimen tal silicosis J Leukoc Biol 76 926932 2004Medline CrossRef 102 Ckless K Lampert A Reiss J Kasahara D Poynter ME Irvin CG Lundblad LK Norton R van der Vliet A JanssenHeininger YM Inhibition arginase activity en hances inflammation mice allergic airway disease association increases protein Snitrosylation tyrosine nitration J Immunol 181 42554264 2008Med line 103 Liu T Dhanasekaran SM Jin H Hu B Tomlins SA Ch innaiyan AM Phan SH FIZZ1 stimulation myo fibroblast differentiation Am J Pathol 164 13151326 2004Medline 104 Liu T Hu B Choi YY Chung M Ullenbruch M Yu H Lowe JB Phan SH Notch1 signaling FIZZ1 induction myofibroblast differentiation Am J Pathol 174 17451755 2009Medline CrossRef 105 Choi ES Pierce EM Jakubzick C Carpenter KJ Kunkel SL Evanoff H Martinez FJ Flaherty KR Moore BB Toews GB Colby TV Kazerooni EA Gross BH Travis WD Hogaboam CM Focal interstitial CC chemokine receptor 7 CCR7 expression idiopathic interstitial pneumonia J Clin Pathol 59 2839 2006Medline CrossRef 106 Pierce EM Carpenter K Jakubzick C Kunkel SL Evanoff H Flaherty KR Martinez FJ Toews GB Hogaboam CM Idiopathic pulmonary fibrosis fibroblasts migrate proliferate CC chemokine ligand 21 Eur Respir J 29 10821093 2007Medline CrossRef 107 Trujillo G Hartigan AJ Hogaboam CM T regula tory cells attenuated bleomycininduced fibrosis lungs CCR7 mice Fibrogenesis Tissue Repair 3 18 2010Medline CrossRef 108 Sobiecka M Kus J Demkow U Filewska M Jozwik A Yoshida Ohnuma Horiuchi et al 23 RadwanRohrenschef P ChorostowskaWynimko J Induced sputum patients interstitial lung disease noninvasive surrogate certain parameters bron choalveolar lavage fluid J Physiol Pharmacol 59Suppl 6 645657 2008Medline 109 FeghaliBostwick CA Tsai CG Valentine VG Kantrow S Stoner MW Pilewski JM Gadgil A George MP Gibson KF Choi AM Kaminski N Zhang Y Duncan SR Cel lular humoral autoreactivity idiopathic pulmonary fibrosis J Immunol 179 25922599 2007Medline 110 van Oosterhout AJ Bloksma N Regulatory Tlympho cytes asthma Eur Respir J 26 918932 2005Medline CrossRef 111 Schubert LA Jeffery E Zhang Y Ramsdell F Ziegler SF Scurfin FOXP3 acts repressor transcription regulates T cell activation J Biol Chem 276 3767237679 2001Medline CrossRef 112 Fontenot JD Gavin MA Rudensky AY Foxp3 pro grams development function CD4CD25 regu latory T cells Nat Immunol 4 330336 2003Medline CrossRef 113 Hori S Nomura T Sakaguchi S Control regulatory T cell development transcription factor Foxp3 Science 299 10571061 2003Medline CrossRef 114 Khattri R Cox T Yasayko SA Ramsdell F An essential role Scurfin CD4CD25 T regulatory cells Nat Im munol 4 337342 2003Medline CrossRef 115 Mack DG Lanham AM Palmer BE Maier LA Fon tenot AP CD27 expression CD4 T cells differentiates effector regulatory T cell subsets lung J Im munol 182 73177324 2009Medline CrossRef 116 Kotsianidis I Nakou E Bouchliou I Tzouvelekis A Spanoudakis E Steiropoulos P Sotiriou I Aidinis V Mar garitis D Tsatalas C Bouros D Global impairment CD4CD25FOXP3 regulatory T cells idiopathic pul monary fibrosis Am J Respir Crit Care Med 179 1121 1130 2009Medline CrossRef 117 Gilani SR Vuga LJ Lindell KO Gibson KF Xue J Ka minski N Valentine VG Lindsay EK George MP Steele C Duncan SR CD28 downregulation circulating CD4 Tcells associated poor prognoses patients idiopathic pulmonary fibrosis PLoS One 5 e8959 2010Medline CrossRef 118 Taflin C Miyara M Nochy D Valeyre D Naccache JM Altare F SalekPeyron P Badoual C Bruneval P Haroche J Mathian A Amoura Z Hill G Gorochov G FoxP3 regulatory T cells suppress early stages granuloma mation little impact sarcoidosis lesions Am J Pathol 174 497508 2009Medline CrossRef 119 Verrecchia F Mauviel A Transforming growth fac torb fibrosis World J Gastroenterol 13 30563062 2007Medline 120 Koli K Myllärniemi M Vuorinen K Salmenkivi K Ryynänen MJ Kinnula VL KeskiOja J Bone mor phogenetic protein4 inhibitor gremlin overexpressed idiopathic pulmonary fibrosis Am J Pathol 169 6171 2006Medline CrossRef 121 Coker RK Laurent GJ Shahzeidi S Lympany PA du Bois RM Jeffery PK McAnulty RJ Transforming growth factorsb1 b2 b3 stimulate fibroblast procollagen production vitro differentially expressed bleomycininduced lung fibrosis Am J Pathol 150 981 991 1997Medline 122 Eickelberg O Köhler E Reichenberger F Bertschin S Woodtli T Erne P Perruchoud AP Roth M Extracellu lar matrix deposition primary human lung fibroblasts response TGFb1 TGFb3 Am J Physiol 276 L814 L824 1999Medline 123 Bobik A Transforming growth factorbs vascular dis orders Arterioscler Thromb Vasc Biol 26 17121720 2006Medline CrossRef 124 Piek E Heldin CH Ten Dijke P Specificity diversity regulation TGFb superfamily signaling FASEB J 13 21052124 1999Medline 125 Leask A Abraham DJ TGFb signaling fibrotic response FASEB J 18 816827 2004Medline Cross Ref 126 Zhao J Shi W Wang YL Chen H Bringas Jr P Datto MB Frederick JP Wang XF Warburton D Smad3 defi ciency attenuates bleomycininduced pulmonary fibrosis mice Am J Physiol Lung Cell Mol Physiol 282 L585 L593 2002Medline 127 Bonniaud P Kolb M Galt T Robertson J Robbins C Stamp fli M Lavery C Margetts PJ Roberts AB Gauldie J Smad3 null mice develop airspace enlargement sistant TGFbmediated pulmonary fibrosis J Immunol 173 20992108 2004Medline 128 Zhang W Ou J Inagaki Y Greenwel P Ramirez F Synergistic cooperation Sp1 Smad3Smad4 mediates transforming growth factor b1 stimulation a2Icollagen COL1A2 transcription J Biol Chem 275 3923739245 2000Medline CrossRef 129 Xu Y Sengupta PK Seto E Smith BD Regulatory fac tor Xbox family proteins differentially interact tone deacetylases repress collagen a2I gene COL1A2 expression J Biol Chem 281 92609270 2006Medline CrossRef 130 Xu Y Farmer SR Smith BD Peroxisome proliferator activated receptor g interacts CIITARFX5 complex repress type I collagen gene expression J Biol Chem 282 2604626056 2007Medline CrossRef 131 Lin X Duan X Liang YY Su Y Wrighton KH Long J Hu M Davis CM Wang J Brunicardi FC Shi Y Chen YG Meng A Feng XH PPM1A functions Smad phos phatase terminate TGFb signaling Cell 125 915928 2006Medline CrossRef 132 Bu S Kapanadze B Hsu T Trojanowska M Opposite effects dihydrosphingosine 1phosphate sphingosine 1phosphate transforming growth factorbSmad signal ing mediated PTENPPM1Adependent pathway J Biol Chem 283 1959319602 2008Medline CrossRef 133 Xin C Ren S Kleuser B Shabahang S Eberhardt W Rade ke H SchäferKorting M Pfeilschifter J Huwiler A 24 Profibrotic Environmental Cues Sphingosine 1phosphate crossactivates Smad signal ing cascade mimics transforming growth factorb induced cell responses J Biol Chem 279 3525535262 2004Medline CrossRef 134 Kono Y Nishiuma T Nishimura Y Kotani Y Okada T Na kamura S Yokoyama M Sphingosine kinase 1 regu lates differentiation human mouse lung fibroblasts mediated TGFb1 Am J Respir Cell Mol Biol 37 395 404 2007Medline CrossRef 135 Zhao J Shi W Chen H Warburton D Smad7 Smad6 differentially modulate transforming growth factor binduced inhibition embryonic lung morphogenesis J Biol Chem 275 2399223997 2000Medline CrossRef 136 Inoue Y Imamura T Regulation TGFb family sig naling E3 ubiquitin ligases Cancer Sci 99 21072112 2008Medline CrossRef 137 Zhang S Fei T Zhang L Zhang R Chen F Ning Y Han Y Feng XH Meng A Chen YG Smad7 antagonizes transforming growth factor b signaling nucleus interfering functional SmadDNA complex formation Mol Cell Biol 27 44884499 2007Medline CrossRef 138 Venkatesan N Pini L Ludwig MS Changes Smad expression subcellular localization bleomycin induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol 287 L1342L1347 2004Medline CrossRef 139 Gonzalez AV Le Bellego F Ludwig MS Imbalance receptorregulated inhibitory Smads lung fibroblasts bleomycinexposed rats Am J Respir Cell Mol Biol 36 206212 2007Medline CrossRef 140 Nakao A Fujii M Matsumura R Kumano K Saito Y Miya zono K Iwamoto I Transient gene transfer expres sion Smad7 prevents bleomycininduced lung fibrosis mice J Clin Invest 104 511 1999Medline CrossRef 141 Wen FQ Liu X Kobayashi T Abe S Fang Q Kohyama T Ertl R Terasaki Y Manouilova L Rennard SI Inter ferong inhibits transforming growth factorb production human airway epithelial cells targeting Smads Am J Respir Cell Mol Biol 30 816822 2004Medline Cross Ref 142 Shukla MN Rose JL Ray R Lathrop KL Ray A Ray P Hepatocyte growth factor inhibits epithelial myofibro blast transition lung cells Smad7 Am J Respir Cell Mol Biol 40 643653 2009Medline CrossRef 143 Csiszar A Ahmad M Smith KE Labinskyy N Gao Q Kal ey G Edwards JG Wolin MS Ungvari Z Bone mor phogenetic protein2 induces proinflammatory endothelial phenotype Am J Pathol 168 629638 2006Medline CrossRef 144 Frank DB Abtahi A Yamaguchi DJ Manning S Shyr Y Pozzi A Baldwin HS Johnson JE Caestecker MP Bone morphogenetic protein 4 promotes pulmonary vascu lar remodeling hypoxic pulmonary hypertension Circ Res 97 496504 2005Medline CrossRef 145 Izumi N Mizuguchi S Inagaki Y Saika S Kawada N Na kajima Y Inoue K Suehiro S Friedman SL Ikeda K BMP7 opposes TGFb1mediated collagen induction mouse pulmonary myofibroblasts Id2 Am J Physi ol Lung Cell Mol Physiol 290 L120L126 2006Medline CrossRef 146 Kowanetz M Valcourt U Bergström R Heldin CH Moustakas A Id2 Id3 define potency cell pro liferation differentiation responses transforming growth factor b bone morphogenetic protein Mol Cell Biol 24 42414254 2004Medline CrossRef 147 Valcourt U Kowanetz M Niimi H Heldin CH Mousta kas A TGFb Smad signaling pathway support tran scriptomic reprogramming epithelialmesenchymal cell transition Mol Biol Cell 16 19872002 2005Med line CrossRef 148 Myllärniemi M Lindholm P Ryynänen MJ Kliment CR Salmenkivi K KeskiOja J Kinnula VL Oury TD Koli K Gremlinmediated decrease bone morphogenetic protein signaling promotes pulmonary fibrosis Am J Respir Crit Care Med 177 321329 2008Medline CrossRef 149 Murray LA Hackett TL Warner SM Shaheen F Argent ieri RL Dudas P Farrell FX Knight DA BMP7 protect bleomycininduced lung skin fibrosis PLoS One 3 e4039 2008Medline CrossRef 150 Pegorier S Campbell GA Kay AB Lloyd CM Bone morphogenetic protein BMP4 BMP7 regulate dif ferentially transforming growth factor TGFb1 mal human lung fibroblasts NHLF Respir Res 11 85 2010Medline CrossRef 151 Koli K Wempe F SternerKock A Kantola A Komor M Hofmann WK von Melchner H KeskiOja J Disrup tion LTBP4 function reduces TGFb activation en hances BMP4 signaling lung J Cell Biol 167 123 133 2004Medline CrossRef 152 Costello CM Cahill E Martin F Gaine S McLoughlin P Role gremlin lung development disease Am J Respir Cell Mol Biol 42 517523 2010Medline CrossRef 153 Wilson MS Wynn TA Pulmonary fibrosis pathogene sis etiology regulation Mucosal Immunol 2 103121 2009Medline CrossRef 154 Gauldie J Kolb M Sime PJ A new direction pathogenesis idiopathic pulmonary fibrosis Respir Res 3 1 2002Medline CrossRef 155 Chua F Gauldie J Laurent GJ Pulmonary fibrosis searching model answers Am J Respir Cell Mol Biol 33 913 2005Medline CrossRef 156 Richeldi L Chronic beryllium disease model pul monary sarcoidosis Acta Biomed 76Suppl 2 1114 2005Medline 157 Chen ES Moller DR Expression profiling granu lomatous lung disease Proc Am Thorac Soc 4 101107 2007Medline CrossRef 158 Gennaro V Ceppi M Crosignani P Montanaro F Re analysis updated mortality vinyl polyvinyl chloride workers confirmation historical evidence new findings BMC Public Health 8 21 2008Medline CrossRef